Literature DB >> 10706520

Drug-polymer conjugates containing acid-cleavable bonds.

F Kratz1, U Beyer, M T Schütte.   

Abstract

Drug-polymer conjugates are potential candidates for the selective delivery of anticancer agents to tumor tissue. Incorporating acid-sensitive bonds between the drug and the polymer is an attractive approach because it ensures effective release of the polymer-bound drug at the tumor site. This release is either extracellular, resulting from the slightly acidic pH in tumor tissue, or intracellular, in acidic endosomes or lysosomes after cellular uptake of the drug-polymer conjugate. This paper reviews acid-sensitive drug-polymer conjugates developed during the past 20 years and outlines aspects for further development in this research field.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10706520     DOI: 10.1615/critrevtherdrugcarriersyst.v16.i3.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  26 in total

1.  Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.

Authors:  U Beyer; B Rothern-Rutishauser; C Unger; H Wunderli-Allenspach; F Kratz
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  Polymer-Based Therapeutics.

Authors:  Shuang Liu; Ronak Maheshwari; Kristi L Kiick
Journal:  Macromolecules       Date:  2009-01-13       Impact factor: 5.985

3.  Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells.

Authors:  Kejin Zhou; Yiguang Wang; Xiaonan Huang; Katherine Luby-Phelps; Baran D Sumer; Jinming Gao
Journal:  Angew Chem Int Ed Engl       Date:  2011-04-14       Impact factor: 15.336

4.  Protease-triggered unveiling of bioactive nanoparticles.

Authors:  Todd J Harris; Geoffrey von Maltzahn; Matthew E Lord; Ji-Ho Park; Amit Agrawal; Dal-Hee Min; Michael J Sailor; Sangeeta N Bhatia
Journal:  Small       Date:  2008-09       Impact factor: 13.281

5.  Advances of cancer therapy by nanotechnology.

Authors:  Xu Wang; Yiqing Wang; Zhuo Georgia Chen; Dong M Shin
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

Review 6.  Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications.

Authors:  Chenjie Xu; Shouheng Sun
Journal:  Dalton Trans       Date:  2009-05-01       Impact factor: 4.390

7.  Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone.

Authors:  Melissa D Howard; Andrei Ponta; Allison Eckman; Michael Jay; Younsoo Bae
Journal:  Pharm Res       Date:  2011-05-26       Impact factor: 4.200

8.  Synthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic Acid conjugate with a hydrolyzable schiff base spacer for treating retinal degeneration.

Authors:  Xueming Wu; Guanping Yu; Chengcai Luo; Akiko Maeda; Ning Zhang; Da Sun; Zhuxian Zhou; Anthony Puntel; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  ACS Nano       Date:  2013-12-20       Impact factor: 15.881

Review 9.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

10.  Rational design of targeted cancer therapeutics through the multiconjugation of folate and cleavable siRNA to RAFT-synthesized (HPMA-s-APMA) copolymers.

Authors:  Adam W York; Faqing Huang; Charles L McCormick
Journal:  Biomacromolecules       Date:  2010-02-08       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.